A Phase 3, Open-label Study to Investigate the Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2, 3 and 4 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Adults
Clinical trial NCT01783678 · COMPLETED
Trial details
- NCT number
- NCT01783678
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2014-04-01
- Enrollment
- 275
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.